Professor Ian Frazer
KOL Consultant
- Co-inventor of the world’s first cervical cancer HPV vaccines, Gardasil® and Cervarix® against cervical cancer, which is now marketed globally by Merck and Cervarix® by GSK.
- Fellow of the Australian Academy of Science, Australian Academy of Health and Medical Sciences, and Royal Society of London. President of the Australian Cancer Society. Nominee for the Nobel Prize in Medicine.
- Recipient of numerous international and Australian awards and honors, including:
– Australian of the Year (2006)
– Gairdner Foundation International Award (2006)
– Lasker-DeBakey Clinical Medical Research Award (2007)
– Kyoto Prize (2008)
– Paul Ehrlich and Ludwig Koch Prize (2010)
– European Inventor Award (2015)
– Tang Prize (2018)
– Hamdan International Award for Medical Excellence (2022)
Professor Mark von Itzstein
KOL Consultant
- A world-leading scientist in anti-viral drug discovery in the field of carbohydrate Glycomics
- Co-inventor of the world’s first ‘designer’ anti-influenza drug, Relenza
- Elected Fellow of the Australian Academy of Science, Australian Academy of Health and Medical Sciences
- Jointly awarded the Australia Prize for pharmaceutical design in 1996. Additionally, received the prestigious Alexander von Humboldt Forschungpreis for foreign scholars in 2001
- Published and patented extensively in Glycoscience. Established strong collaborations locally and internationally
Professor Chris Parish
KOL Consultant
- A renowned immunologist with over 45 years of research experience investigating various aspects of the immune system. Inventor of the Th1/Th2 paradigm in immunology
- For decades, his research focused on carbohydrates involved in cell adhesion and cell migration. This work led to the discovery of heparinase, an enzyme involved in inflammation and tumor metastasis, and its subsequent inhibitor, PI88, which was clinically developed
- He received a number of awards and medals, including the Clive and Vera Ramaciotti Medal for Excellence in Biomedical Research in recognition of his scientific achievements
Jason Zhang
Key Business Partners & Chief Finance Officer
- Chartered Accountant (CA), Certified Public Accountant (CPA), and Chartered Tax Adviser
- Over 15 years of working experience of accounting, taxation and business advisory services to a broad spectrum of clients ranging from high-net-worth individuals to large enterprises and subsidiaries of foreign multinationals
- Advisor to a number of ASX companies and NFP boards.
- Expertise in international tax with a strong track record of providing practical and value-driven strategic tax solutions to clients.
- Regularly assists clients with M&A, due diligence, and cross-border joint venture tasks.
- A member of Chartered Accountants Australia and New Zealand and Chartered Tax Advisor accredited by The Tax Institute
Neil Finlayson (BSc -Hons, BCom), (Director: Neil Finlayson Consulting)
Chief Operating Officer (COO)
- Over 30 years of work experience in management, clinical development and commercialisation within the biotechnology sector. Held senior roles in business development and been CEO for a number of clinical stage biotech companies. Extensive experience in clinical trials (Phases I and II), banking and finance, Joint Ventures, partnering and out-licensing, and in company formations
- Previously, CEO of DNA vaccine developer Admedus Vaccines Pty Ltd, founded by Prof. Ian Frazer (co-inventor of the world’s first cancer vaccine)
- Previously held positions include Director and CEO of Jingang Medicine (Australia) Pty Ltd; CEO of Vaccine Solutions Pty Ltd (co-owned by CSL Limited and QIMR Berghofer); Executive Officer of the Cooperative Research Centre for Vaccine Technology (a $42M joint venture); Business Development Director of Bio Innovation SA; Founding Director of AbRegen Pty Ltd; and Director of Commercialisation at Griffith University
- Previously member of the Australian Association of Angel Investors Limited; the Australian Institute of Company Directors; and the University of South Australia, School of Pharmacy and Medical Sciences Pharmaceutical Science Advisory Committee
Dr. Audrey Jia (MD, PhD, MS)
Non-Executive Director & Former FDA Senior CMC Reviewer
- More than 20 years of combined experience in biologic product development and the FDA CMC review
- Very experienced in IND and BLA review
- Very experienced in GMP mock inspections of biologics and small molecules
- Strong experience in US/China regulatory strategy
- Experienced in novel and biosimilar for Mab, Bispecific, ADC, cytokines, peptide, insulin, mRNA vaccines etc
- M.D., Peking University; Ph.D. in Biochemistry, Emory University; M.S. in Bioscience Regulatory Affairs, Johns Hopkins University
Nicoletta Muner (BPharm -Hons, MPharmSci, GAICD, MMPP), (Founder and Managing Director: Canary Regulatory Affairs)
Senior Vice President – Global Regulatory Affairs
- More than 25 years experience in the pharmaceutical industry, spanning product, pre-clinical and clinical development, and international regulatory affairs
- Expert in global regulatory strategy development and in obtaining scientific advice from the EMA, EU National Competent Authorities, FDA (Pre-IND, Type C, EOP2, Pre-NDA/BLA), MHRA and TGA
- Extensive experience in regulatory submissions, including Orphan Drug Designation (ODD), Rare Pediatric Disease Designation (RPDD), accelerated pathways, IND application, Pediatric Study/Investigational Plans (PSP/PIP), New Drug Application (NDA) submissions and EU Marketing Authorisation Application (MAA) filings via Centralised and Decentralised Procedures
- Successfully registered a first-in-class orphan medicinal product in the European Union and the United States
- Experienced in the design and project management of nonclinical studies
- Experienced in the preparation of Investigator’s Brochures and Clinical Study Protocols
- Bachelor’s degree in Pharmaceutical Chemistry and Technologies from the University of Trieste (Italy) including a research project conducted at the University of Regensburg (Germany)
- Awarded First-Class Honours and Master’s degree in Pharmaceutical Sciences from Monash University (Australia)
- Graduate of the Australian Institute of Company Directors (AICD)
Andrew Jaworski (LLB (Hons), BOptom, GradDipLaw (Comm), GradCert TMLP, AFCHSM, CHM, GAICD, CIPT, CIPM, FGIA)
Senior Vice President – Legal and Business Affairs
- Dual-qualified lawyer admitted in Australia and England & Wales, with more than 20 years’ experience across corporate and commercial law and deep experience in the health, research and technology sectors.
- Managing Principal of First Port Legal, with senior executive experience across Big 4 advisory, international top-tier law firms, global multinationals and the public sector in the UK, APAC and ASEAN regions.
- Routinely advises boards, founders and executive teams on corporate and commercial matters, including M&A, joint ventures, strategic partnerships, risk management, compliance, privacy, AI, technology, IP and cross-border transactions.
- Graduate of the Australian Institute of Company Directors and Fellow of the Governance Institute of Australia, with several non-executive director, company secretary and advisory board member roles, advising on governance, compliance and regulatory frameworks across the private, public and not-for-profit sectors.
- Award winning lawyer, with recent recognition as Sole Legal Counsel of the Year at the Lawyers Weekly Corporate Counsel Awards 2026, and broader industry recognition with awards across health/biotech, not-for-profit and professional excellence.
Dr.Pavel Reddy
Key Business Partners & Senior R&D Tax Advisor
- Over 17 years of experience as an R&D Tax Advisor. Registered with the Australian Tax Practitioners Board. Proven track record working with Big 4 consulting firms and leading Australian R&D Tax Consultancies.Extensive experience working with companies across various industries, from startups to multinational corporations.
- Global network: Collaborates with government departments, incubators, accelerators, and tech companies in Biotech, Life Sciences, MedTech, and Pharma across China, EU, Singapore, South Korea, UK, and the USA.
- Diverse expertise: Identifies eligible R&D activities across various sectors due to a varied background and experience. Consulting experience spans life sciences, IT, food & beverage, engineering, and manufacturing.
- Proven track record: Successfully submitted and defended numerous clients’ R&D tax claims, prepared and lodged Advance and Overseas Findings.
- Academic background: PhD in Biological Sciences. Previously lectured at three tertiary institutions for 18 years. Conducts both personal and collaborative research, with publications in peer-reviewed scientific journals.
Professor Jack Wong
Non-Executive Director & Regulatory Affairs Expert
- Over 25 years of experience in regulatory and quality network in APAC including Australia and New Zealand with good knowledge in the field of Nutritional, Pharmaceuticals, Medical Devices, Consumer Healthcare and Biological products
- Founder of the biggest regulatory association with over 7000 members in the APAC region
- Author of many Handbooks of Regulatory Affairs in Asia and developed many training courses in regulatory affairs
- Adjunct Professor/Lecturer in Chinese University of Hong Kong, National University of Singapore and Tohoku University Japan
- CEO of RNAscence (a Biotech startup spin off from Nanyang Technological University and National Skin Center Singapore)
Stella Chen
Non-Executive Director & Medical Device Registration Expert
- Over 20 years of experience in pharmaceutical and medical device regulatory registration and quality management, with expertise in registration, clinical trials, and international certification
- Led the establishment of quality systems in more than 10 subsidiaries of the AILEX Group, passing multiple regulatory inspections by drug administration bureaus and TÜV Süd
- Secured over 200 medical device registration certificates, with Class III devices accounting for more than 10%
- Served in quality management roles in several well-known pharmaceutical companies and has been with the AILEX Group for over a decade. Currently serves as the General Manager of Shinying Medical Devices, focusing on global registration and consulting services
- Holds an MBA in Big Health Industry from East China University of Science and Technology and a Bachelor’s degree in Pharmacy from Zhejiang Chinese Medical University
- A licensed pharmacist and the head of the Big Health Industry Management Club at East China University of Science and Technology
Ding Yi Xu
Executive Consultant - R&D Strategy (New Zealand)
- 1982 BEng, Shanghai Jiaotong University,1987 MEng, Auckland University
- Shanghai Second Medical University, Lecture
- Molecular Medicine Department, Auckland Medical School, Research Scientist
- Genesis Research & Development Corp (NZ) Ltd, Head of IT & Bioinformatics
- Psychiatric Genomics (USA) Inc., Director of IT & Bioinformatics
- New Zealand Science Technology and Education Promotion Centre, Director
Shanghai Jiaotong University (NZ) Alumni, VP - New Zealand-China Association for the Promotion of Economy& Science, Exec VP
- New Zealand Institute of Environment Science & Research (ESR), Principal Advisor
- Otago University Business School, Principal Advisor
- Otago Polytechnic (Auckland International Campus), Senior Advisor
Ophthalmologist - Dr. Lucy Chen
Key Clinical Specialist Consultant
- Ophthalmologist, active License of California & Texas Board of Optometry, USA, Active Medical License of China
- Clinical Investigator Certification (CIC) & Fellow of AAO
- University of Houston, USA, Doctor of Optometry (OD) (BSK)
- University of Alcalá del Henares, Spain, PhD (Subsaliente cum Laude)
Obstetrics and Gynecology Specialist Professor Lina Hu
Key Clinical Specialist Consultant
- Professor, Chief Physician, Doctoral Supervisor, Recipient of the Special Allowance from the State Council
Current Positions:
- Expert Reviewer for New Drugs and Medical Devices, National Medical Products Administration
- Member of the Medical Device Standards Committee and the Gynecology and Obstetrics Reproduction and Family Planning Committee
- Academic and Technical Leader in Sichuan Province and Chongqing Municipality
- Standing Member of the Reproductive Medicine Committee of the Chinese Medical Association
- Director of the Reproductive and Developmental Stem Cell Engineering Center of Chongqing Municipality
- President of the Chongqing Society of Sexology
Otolaryngologist - Professor Bobei Chen
Key Clinical Specialist Consultant
- Professor, Chief Physician, Supervisor of Master’s Students
- Director of the Department of Otolaryngology, Wenzhou Medical University Affiliated Second Hospital
Current Positions:
- Consultant, Pediatric Section, Chinese Society of Otolaryngology
- Deputy Director, Pediatric Dizziness Group, Chinese Society of Rehabilitation Medicine
- Vice President, Otolaryngology Branch, Zhejiang Provincial Medical Association
- Vice Chairman, Wenzhou Medical Association, Otolaryngology Society
- Reviewer, Chinese Journal of Otolaryngology, Head and Neck Surgery
- Editorial Board Member, Journal of Wenzhou Medical University
Dermatologist - Professor Hao Chen
Key Clinical Specialist Consultant
- Professor, Chief Physician, Doctoral Supervisor
Current Positions:
- Director of Dermatology, Shaoxing People’s Hospital, Zhejiang University School of Medicine
- Vice Director, Academic Affairs, Graduate Education Committee, Zhejiang University School of Medicine
- Member, Dermatology Branch, Chinese Medical Association
- Deputy Director, Dermatology and Venereology Branch, Zhejiang Provincial Medical Association
- Deputy Chairperson, Dermatology Physician Branch, Zhejiang Provincial Medical Association